These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7047824)

  • 1. [Aldosterone response to metoclopramide, a dopaminergic inhibitor, in normal men; evaluation of the mechanisms (author's transl)].
    Mizuno K; Yamazaki M; Toki T; Ono Y; Hashimoto S; Yaginuma K; Nagasawa S; Fukuchi S
    Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):175-80. PubMed ID: 7047824
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lack of effect of aging on dopaminergic inhibition of aldosterone and prolactin increase].
    Preis P; Luger A; Templ H; Tragl HK; Geyer G
    Z Gerontol; 1985; 18(4):241-3. PubMed ID: 3901563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic modulation of aldosterone secretion: effect of sodium balance and postural changes.
    García-Robles R; Ruilope L; Mancheño E; Hurtado A; Alcázar JM; Varela C; de la Calle H; Rodicio JL; Sancho J
    Rev Esp Fisiol; 1984 Mar; 40(1):63-8. PubMed ID: 6087430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of metoclopramide on plasma aldosterone in normal subjects, primary aldosteronism and hypopituitarism.
    Mantero F; Opocher G; Boscaro M; Valpione E; Armanini D; Fallo F
    Horm Metab Res; 1981 Aug; 13(8):464-7. PubMed ID: 7035323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum aldosterone response to metoclopramide in normal subjects and acromegalic patients.
    Zacharieva S; Stoeva I; Matrozov P; Andonova K
    Exp Clin Endocrinol; 1990 Aug; 95(3):331-8. PubMed ID: 2245821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of metoclopramide-induced prolactin on aldosterone secretion in normal subjects.
    Ogihara T; Matsumura S; Onishi T; Miyai K; Uozumi T
    Life Sci; 1977 Feb; 20(3):523-6. PubMed ID: 839976
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of captopril on the plasma aldosterone response to metoclopramide in normal subjects].
    Zachariéva S; Koev D; Tcharaktchiev D; Moskov M; Andonova K
    Ann Endocrinol (Paris); 1989; 50(3):233-6. PubMed ID: 2683976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine control of aldosterone secretion in end-stage renal failure.
    García-Robles R; Ruilope L; Tovar J; de Villa LF; Miranda B; Prieto C; Parada J; Sancho J; Rodicio JL
    Rev Esp Fisiol; 1986 Jun; 42(2):257-63. PubMed ID: 3092288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of pizotifen, a serotonin antagonist, and of pirenzepine, a muscarinic antagonist, on hormonal responses to metoclopramide in healthy subjects.
    Jungmann E; Althoff PH; Hermann GJ; Schöffling K
    Arzneimittelforschung; 1984; 34(9):1022-4. PubMed ID: 6391497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma aldosterone response to metoclopramide in patients with Cushing's disease.
    Zacharieva S; Stoeva I; Matrozov P; Andonova K
    Exp Clin Endocrinol; 1993; 101(3):138-43. PubMed ID: 8223981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic modulation of aldosterone secretion in the normal menstrual cycle.
    Garcia-Robles R; Ruilope LM; Tovar J; de Pablos P; Parada J; Hurtado A; Miranda B; Fernandez Vazquez G; Rodicio JL; Sancho J
    J Clin Hypertens; 1987 Dec; 3(4):470-8. PubMed ID: 3134515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyper-responsiveness of aldosterone to metoclopramide in aldosteronism.
    Gniadek TC; Grekin RJ; Gross MD; Villareal JZ
    Clin Endocrinol (Oxf); 1982 May; 16(5):475-81. PubMed ID: 7044619
    [No Abstract]   [Full Text] [Related]  

  • 14. Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.
    Zacharieva S; Stoeva I; Andreeva M; Kalinov K; Matrozov P; Andonova K
    Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):593-7. PubMed ID: 9010834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ganglionic blockade with trimethaphan on corticosteroid responses to metoclopramide in rhesus monkeys.
    Sowers JR; Beck FW; Eggena P
    J Hypertens; 1984 Aug; 2(4):367-70. PubMed ID: 6152278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of metoclopramide, a dopamine inhibitor, on aldosterone secretion in patients with primary aldosteronism].
    Mizuno K; Yaginuma K; Yamazaki M; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1982 Aug; 58(8):976-83. PubMed ID: 6292008
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhanced response of plasma prolactin to metoclopramide during chronic converting enzyme inhibition.
    Dupont AG; Van der Nipen P; Van Steirteghem AC; Vanhaelst L
    Horm Metab Res; 1987 May; 19(5):212-5. PubMed ID: 3034757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic Modulation of renin activity and aldosterone and prolactin secretion in the spontaneously hypertensive rat.
    Sowers JR; Sollars EG; Tuck ML; Asp ND
    Proc Soc Exp Biol Med; 1980 Sep; 164(4):598-603. PubMed ID: 6997889
    [No Abstract]   [Full Text] [Related]  

  • 19. [Variations of the renin aldosterone system in Cushing's disease (author's transl)].
    Bricaire H; Thibonnier M; Hautecouverture M; Corvol P; Luton JP
    Nouv Presse Med; 1980 Mar; 9(14):1007-9. PubMed ID: 6988802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metoclopramide-induced changes in plasma aldosterone "in vivo" are independent from renin-angiotensin system activity.
    Bernardi M; De Palma R; Trevisani F; Malatesta R; Gasbarrini G
    Horm Metab Res; 1988 Aug; 20(8):532-4. PubMed ID: 3053390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.